Myasthenia Gravis Presenting as Graft versus Host Disease after Allogeneic Blood Stem Cell Transplant

Myasthenia gravis is a very rare manifestation of graft versus host disease after stem cell transplants. Herein, we describe a case of new-onset myasthenia gravis after a stem cell transplant 34 months ago in a patient with myelodysplastic syndrome.

Detalles Bibliográficos
Autores principales: Ahmed, Zarir, Schoen, Martin, Rajeh, Nabeel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079576/
https://www.ncbi.nlm.nih.gov/pubmed/30116647
http://dx.doi.org/10.1155/2018/7296930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079576/
https://www.ncbi.nlm.nih.gov/pubmed/30116647
http://dx.doi.org/10.1155/2018/7296930

Ejemplares similares